A detailed history of Davenport & CO LLC transactions in Esperion Therapeutics, Inc. stock. As of the latest transaction made, Davenport & CO LLC holds 10,000 shares of ESPR stock, worth $20,299. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,000
Previous 30,000 66.67%
Holding current value
$20,299
Previous $66,000 75.76%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

SELL
$1.61 - $2.73 $32,200 - $54,600
-20,000 Reduced 66.67%
10,000 $16,000
Q2 2024

Aug 06, 2024

BUY
$1.84 - $3.24 $55,200 - $97,200
30,000 New
30,000 $66,000

Others Institutions Holding ESPR

About Esperion Therapeutics, Inc.


  • Ticker ESPR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 66,551,600
  • Market Cap $135M
  • Description
  • Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...
More about ESPR
Track This Portfolio

Track Davenport & CO LLC Portfolio

Follow Davenport & CO LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Davenport & CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Davenport & CO LLC with notifications on news.